2025-03-27
Wegovy sales took a hit this year. Novo's CEO blames off-brand competition
Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy took a hit due to rising competition from off-brand, or compounded, versions of the treatment, according to the Danish pharma giant’s CEO Lars Fruergaard Jørgensen.
[...]Rating
Innovation
Pricing
Technology
Usability
We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.
2025-05-24
Best Memorial Day tech sales from Amazon, Apple, Samsung, Dyson and others
It might surprise you, but Memorial Day can be a great time to shop for tech. In years past, we've seen solid Memorial Day sales on all manner of gadgets including many of our favorite tablets, h [...]
2025-05-22
Best Memorial Day tech sales from Amazon, Apple, Samsung and others that you can shop now
It might surprise you, but Memorial Day can be a great time to shop for tech. In years past, we've seen solid Memorial Day sales on all manner of gadgets including many of our favorite tablets, h [...]
2025-05-26
The best Memorial Day tech sales from Amazon, Apple, Samsung, Dyson and others that you can get today
It might surprise you, but Memorial Day can be a great time to shop for tech. In years past, we've seen solid Memorial Day sales on all manner of gadgets including many of our favorite tablets, h [...]
2025-05-20
Best Memorial Day tech sales from Amazon, Apple, Dyson and others that you can shop now
It might surprise you, but Memorial Day can be a great time to shop for tech. In years past, we've seen solid Memorial Day deals on all manner of gadgets including many of our favorite tablets, h [...]
2025-05-16
Novo Nordisk's CEO is out after the Ozempic maker's stock dropped 50% in a year
Novo Nordisk (NVO) CEO Lars Fruergaard Jørgensen will step down after eight years at the helm of the Danish pharmaceutical giant responsible for the blockbuster drugs Ozempic and Wegovy, the company [...]
2025-03-28
Cheaper Wegovy, 23andMe shutters, and RFK Jr. cuts FDA jobs: Pharma news roundup
Novo Nordisk is expanding its cash-only savings program offering its blockbuster weight-loss drug Wegovy for $499 a month at all U.S. pharmacies. 23andMe has filed for Chapter 11 bankruptcy protection [...]
2025-05-30
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race
Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]